JVIR CME June 2025

This month's journal based article is titled: The Incidence and Consequences of Endovascular Technical Failure in Patients with Chronic Limb Threatening Ischemia

This is a post-hoc analysis of the prospective, randomized, multicenter trial for Best Surgical versus Best Endovascular Therapy in Patients with Critical Limb Ischemia (BEST-CLI).  Specifically, the authors evaluated the etiology and clinical impact of endovascular technical failure (ETF) compared to those patients who did not have ETF.

Following completion of this CME activity, the participant will be able to:

1. Understand the frequency of ETF in the BEST-CLI trial

2. Understand the risk factors for endovascular technical failure

3. Discuss the clinical impact after ETF

This program is designed to meet the educational needs of interventional radiologists, nurses, techs and trainees at all levels.

CME Editor
Daniel Sheeran, M.D.
University of Virginia, Charlottesville, VA

Content and Scope
As the official journal of the Society of Interventional Radiology, JVIR is the peer-reviewed journal of choice for radiologists, cardiologists, vascular surgeons, neurosurgeons, and other clinicians who need current and reliable information on every aspect of vascular and interventional radiology. Each article goes through a peer review process to validate that the content is matched to the current or potential scope of our learners and that any disclosures submitted do not introduce a conflict or bias within the scientific article.  

Accreditation Statement
This activity has been planned and implemented in accordance with the Essentials and Standards of the Accreditation Council for Continuing Medical Education (ACCME).

The Society of Interventional Radiology (SIR) is accredited by the ACCME to provide continuing medical education for physicians. SIR designates this education activity for a maximum of 1.00 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.